ArticleBMJ open2025

HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction.

Benjamin Dowsing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.